Guidance

BBVs in healthcare workers: health clearance and management

Guidance for health clearance of healthcare workers (HCWs) and management of those infected with bloodborne viruses (BBVs) hepatitis B, hepatitis C and HIV.

From:
UK Health Security Agency
Published
26 October 2017
Last updated
24 April 2024 — See all updates

Documents

Integrated guidance on health clearance and the management of HCWs living with BBVs (hepatitis B, hepatitis C and HIV): April 2024

Ref: UKHSA publications number: GOV-16578

PDF, 703 KB, 63 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

See also Integrated guidance on health clearance and the management of HCWs living with BBVs (hepatitis B, hepatitis C and HIV): quick reference guide.

This guidance provides information on:

  • health clearance for hepatitis B, hepatitis C and HIV for new healthcare workers
  • management of healthcare workers infected with hepatitis B, hepatitis C or HIV, including monitoring arrangements for those performing exposure prone procedures
  • guidance and arrangements for undertaking patient notification exercises following the diagnosis of healthcare workers with hepatitis B, hepatitis C or HIV
  • roles and responsibilities of the UK Advisory Panel on healthcare workers with blood borne viruses (UKAP) and other parties involved in the management of healthcare workers infected with hepatitis B, hepatitis C or HIV
Published 26 October 2017
Last updated 24 April 2024 + show all updates

  1. Updated with April 2024 integrated guidance to include notification and advice on the discontinuation of the UKAP occupational health monitoring register.

  2. Updated with November 2023 integrated guidance.

  3. Updated hepatitis B reactivation in the November 2022 integrated guidance.

  4. Updated November 2021 report and reference guide.

  5. Revised guidance on HCV post-treatment period, with updated definition on roles and responsibilities of stakeholders and scope of the guidance.

  6. Updated 'Integrated guidance on health clearance and the management of healthcare workers living with bloodborne viruses (hepatitis B, hepatitis C and HIV): July 2019' report and reference guide.

  7. First published.

Related content